Interruption of the OX40–OX40 Ligand Pathway in LDL Receptor–Deficient Mice Causes Regression of Atherosclerosis

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Journal of Immunology

• Publication date

  2013-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.1200708PMID 24068673
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Classical Macrophage Activation Up-Regulates Several Matrix Metalloproteinases through Mitogen Activated Protein Kinases and Nuclear Factor-κB

  2012cited by this paper
• Suppressed monocyte recruitment drives macrophage removal from atherosclerotic plaques of Apoe-/- mice during disease regression.

  2011cited by this paper
• Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis.

  2011cited by this paper
• IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice.

  2011cited by this paper
• IL-33 Reduces Macrophage Foam Cell Formation

  2010cited by this paper
• OX40 ligand plays an important role in the development of atherosclerosis through vasa vasorum neovascularization.

  2010cited by this paper
• LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.

  2010cited by this paper
• Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice

  2010cited by this paper
• Genetic variants of TNFSF4 and risk for carotid artery disease and stroke

  2009cited by this paper
• LXR agonist suppresses atherosclerotic lesion growth and promotes lesion regression in ApoE*3Leiden mice: time course and potential mechanisms

  2008cited by this paper
• The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel ‘Alarmin’?

  2008cited by this paper
• IL-33 Induces Antigen-Specific IL-5+ T Cells and Promotes Allergic-Induced Airway Inflammation Independent of IL-41

  2008cited by this paper
• Plasma interleukin-5 levels are related to antibodies binding to oxidized low-density lipoprotein and to decreased subclinical atherosclerosis.

  2008cited by this paper
• IL-33 reduces the development of atherosclerosis

  2008cited by this paper
• IL-33 induced Ag-specific IL-5+ T cells and promotes allergic-induced airway inflammation independent of IL-4

  2008cited by this paper
• Perivascular Mast Cells Promote Atherogenesis and Induce Plaque Destabilization in Apolipoprotein E–Deficient Mice

  2007cited by this paper
• Effects of reconstituted high-density lipoprotein infusions on coronary atherosclerosis: a randomized controlled trial.

  2007cited by this paper
• Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.

  2007cited by this paper
• Effect of torcetrapib on the progression of coronary atherosclerosis.

  2007cited by this paper
• Interruption of the Tnfrsf4/Tnfsf4 (OX40/OX40L) Pathway Attenuates Atherogenesis in Low-Density Lipoprotein Receptor–Deficient Mice

  2007influential reference
• The immune response in atherosclerosis: a double-edged sword

  2006cited by this paper
• Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial.

  2006cited by this paper
• Mast Cells Enhance T Cell Activation: Importance of Mast Cell Costimulatory Molecules and Secreted TNF1

  2006cited by this paper
• Blockade of OX40‐ligand after initial triggering of the T helper 2 response inhibits mercuric chloride‐induced autoimmunity

  2006cited by this paper
• Human genetic evidence that OX40 is implicated in myocardial infarction.

  2006cited by this paper
• Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis Published, JLR Papers in Press, May 16, 2005. DOI 10.1194/jlr.R500005-JLR200

  2005cited by this paper
• IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.

  2005influential reference
• Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility

  2005cited by this paper
• Effect of intensive lipid lowering on progression of coronary atherosclerosis: evidence for an early benefit from the Reversal of Atherosclerosis with Aggressive Lipid Lowering (REVERSAL) trial.

  2005cited by this paper
• The role of natural antibodies in atherogenesis.

  2005cited by this paper
• Triggering of OX40 (CD134) on CD4(+)CD25+ T cells blocks their inhibitory activity: a novel regulatory role for OX40 and its comparison with GITR.

  2005cited by this paper
• IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

  2004cited by this paper
• Apoptotic Cells with Oxidation-specific Epitopes Are Immunogenic and Proinflammatory

  2004cited by this paper
• Inhibition of atherosclerosis in apolipoprotein-E-deficient mice following muscle transduction with adeno-associated virus vectors encoding human apolipoprotein-E

  2002cited by this paper
• Costimulatory molecule OX40L is critical for both Th1 and Th2 responses in allergic inflammation

  2002cited by this paper
• Nerve growth factor levels and mast cell distribution in human coronary atherosclerosis.

  2001cited by this paper
• Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

  2001cited by this paper
• Correlation of peripheral blood OX40+(CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation.

  2001cited by this paper
• Critical Contribution of Ox40 Ligand to T Helper Cell Type 2 Differentiation in Experimental Leishmaniasis

  2000cited by this paper
• Contribution of OX40/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis

  2000cited by this paper
• Complete atherosclerosis regression after human ApoE gene transfer in ApoE-deficient/nude mice.

  2000cited by this paper
• T cell co-stimulatory molecules other than CD28.

  1999cited by this paper
• Blocking OX-40/OX-40 ligand interaction in vitro and in vivo leads to decreased T cell function and amelioration of experimental allergic encephalomyelitis.

  1999cited by this paper
• Association between myocardial infarction and the mast cells in the adventitia of the infarct-related coronary artery.

  1999cited by this paper
• Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M.

  1998cited by this paper
• The transcription factor GATA-3 is necessary and sufficient for Th2 cytokine gene expression in CD4 T cells.

  1997cited by this paper
• Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted State6 gene

  1996cited by this paper
• The T cell-B cell interaction via OX40-OX40L is necessary for the T cell-dependent humoral immune response

  1996cited by this paper
• Levels of IgE in the serum of patients with coronary arterial disease.

  1991cited by this paper
• Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors

  1988cited by this paper
• Ath-1, a gene determining atherosclerosis susceptibility and high density lipoprotein levels in mice.

  1987cited by this paper
• Sequential morphologic studies of regression of advanced atherosclerosis.

  1981cited by this paper

• Downregulation of oar-miR-125b Drives Blood–Brain Barrier Breakdown Through the TNFSF4–NF-κB Inflammatory Axis in Enterococcus Faecalis Meningitis

  2025cites this paper
• TNF superfamily molecules in atherosclerosis: mechanistic insights and therapeutic translation

  2025cites this paper
• Costimulatory and Coinhibitory Immune Checkpoints in Atherosclerosis

  2024cites this paper
• Cellular and Molecular Mechanisms of Mast Cells in Atherosclerotic Plaque Progression and Destabilization

  2024cites this paper
• TNF superfamily control of tissue remodeling and fibrosis

  2023cites this paper
• X-box Binding Protein 1: An Adaptor in the Pathogenesis of Atherosclerosis

  2023cites this paper
• Single-cell RNA sequencing atlas of peripheral blood mononuclear cells from subjects with coronary artery disease.

  2023cites this paper
• CHECKPOINT ATHERO: developing immune checkpoint-based therapeutics for atherosclerosis.

  2023cites this paper
• Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?

  2022cites this paper
• OX40L enhances the immunogenicity of dendritic cells and inhibits tumor metastasis in mice

  2022cites this paper
• Vascular inflammation in cardiovascular disease: Is Immune system protective or bystander.

  2021cites this paper
• The Paradigm Change of IL-33 in Vascular Biology

  2021cites this paper
• Stimulation of the PD-1 Pathway Decreases Atherosclerotic Lesion Development in Ldlr Deficient Mice

  2021cites this paper
• B Cells in Atherosclerosis

  2021cites this paper
• A myriad of roles of dendritic cells in atherosclerosis

  2021cites this paper
• Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans

  2020cites this paper
• T cell subsets and functions in atherosclerosis

  2020cites this paper
• Glucocorticoid-induced tumour necrosis factor receptor family-related protein (GITR) drives atherosclerosis in mice and is associated with an unstable plaque phenotype and cerebrovascular events in humans

  2020cites this paper
• The OX40 Axis is Associated with Both Systemic and Local Involvement in Atopic Dermatitis

  2020cites this paper
• Tc17 CD8+ T cells accumulate in murine atherosclerotic lesions, but do not contribute to early atherosclerosis development

  2020cites this paper
• The role of OX40L and ICAM-1 in the stability of coronary atherosclerotic plaques and their relationship with sudden coronary death

  2019cites this paper
• Atherosclerosis: An Age-Dependent Autoimmune Disease

  2019cites this paper
• Hypercholesterolemia Induces a Mast Cell–CD4+ T Cell Interaction in Atherosclerosis

  2019cites this paper
• T cell co-stimulation and co-inhibition in cardiovascular disease: a double-edged sword

  2019cites this paper
• Naringenin enhances the regression of atherosclerosis induced by a chow diet in Ldlr-/- mice.

  2019cites this paper
• Macrophages and T cells in atherosclerosis: a translational perspective.

  2019cites this paper
• Helicobacter Pylori Induces GATA3-Dependent Chitinase 3 Like 1 (CHI3L1) Upregulation and Contributes to Vascular Endothelial Injuries

  2019cites this paper
• Antisense Oligonucleotide Inhibition of MicroRNA-494 Halts Atherosclerotic Plaque Progression and Promotes Plaque Stabilization

  2019cites this paper
• T Cells in Atherosclerosis in Ldlr−/− and Apoe−/− Mice

  2018cites this paper
• 2016 Jeffrey M. Hoeg Award Lecture: Immune Checkpoints in Atherosclerosis Toward Immunotherapy for Atheroprotection

  2018cites this paper
• Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

  2017cites this paper
• Metabolism-associated danger signal-induced immune response and reverse immune checkpoint-activated CD40+ monocyte differentiation

  2017cites this paper
• Recent advances on CD4+ T cells in atherosclerosis and its implications for therapy

  2017influential citation
• Arteriosclerosis, Thrombosis, and Vascular Biology.

  2017cites this paper
• ATVB Distinguished Scientist Award: How Costimulatory and Coinhibitory Pathways Shape Atherosclerosis

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• Mast cells in atherosclerotic cardiovascular disease – Activators and actions

  2017cites this paper
• Immune checkpoint proteins: exploring their therapeutic potential to regulate atherosclerosis

  2017cites this paper
• Readapting the adaptive immune response – therapeutic strategies for atherosclerosis

  2017cites this paper
• The impact of mast cells on cardiovascular diseases.

  2016cites this paper
• OX40 regulates pressure overload-induced cardiac hypertrophy and remodelling via CD4+ T-cells.

  2016cites this paper
• Atherosclerosis: the interplay between lipids and immune cells

  2016cites this paper
• Higher circulating levels of chemokines CXCL10, CCL20 and CCL22 in patients with ischemic heart disease.

  2016cites this paper
• Novel immune cell-based therapies for atherosclerosis

  2015cites this paper
• Regulation of atherosclerotic plaque inflammation

  2015cites this paper
• IL-25 Inhibits Atherosclerosis Development in Apolipoprotein E Deficient Mice

  2015influential citation
• Mast Cells as Effectors in Atherosclerosis

  2015cites this paper
• Targeting the adaptive immune system: new strategies in the treatment of atherosclerosis

  2015influential citation
• Use of Mouse Models in Atherosclerosis Research.

  2015cites this paper
• Regulatory Immune Responses and Repair Mechanisms in Atherosclerosis

  2015cites this paper
• Thérapie ciblée anti-OX40 Ligand dans des modèles murins de Sclérodermie systémique

  2015cites this paper
• Mast cells in human and experimental cardiometabolic diseases

  2015cites this paper
• β-Catenin Signaling in Dendritic Cells Reduces Atherosclerosis

  2015cites this paper
• Adaptive (T and B Cells) Immunity and Control by Dendritic Cells in Atherosclerosis

  2014cites this paper
• GITR promoter polymorphism contributes to risk of coal workers' pneumoconiosis: a case-control study from China.

  2014cites this paper
• I-L-C-2 it: type 2 immunity and group 2 innate lymphoid cells in homeostasis.

  2014cites this paper
• The mutual interplay of lipid metabolism and the cells of the immune system in relation to atherosclerosis

  2014cites this paper
• The dynamic lives of macrophage and dendritic cell subsets in atherosclerosis

  2014cites this paper
• Regulation of immune responses in atherosclerosis

  2013cites this paper
• Modulation of Atherosclerotic Lesions by Circulating Cells : The Translational Spectrum

  year unknowncites this paper